南财智讯1月30日电，佛慈制药在投资者关系活动中表示，公司产品已出口至32个国家和地区，海外产 品注册数达1442个，在国外认证数量、海外商标注册、出口覆盖范围及品种数方面长期居于行业领先地 位；公司将持续深化国际化战略布局，依托出口优势加大海外建设投入，推进产品国际注册与合规认 证，通过品牌共建、渠道共享强化推广，不断扩大海外市场份额。 ...

Core Viewpoint - The company aims to strengthen its domestic market sales while actively developing potential markets by implementing differentiated product sales strategies and leveraging e-commerce platforms like JD and Tmall to enhance market share [1] Group 1: Sales Strategy - The company plans to consolidate its existing domestic market sales while exploring new potential markets in the first half of 2025 [1] - A systematic review of different channels and key customers will be conducted to formulate differentiated product sales policies [1] - The integration of online and offline sales through e-commerce platforms is a key focus to boost product market share [1] Group 2: Sales Channel Distribution - Currently, over 60% of sales come from commercial chain channels, approximately 20% from medical channels, and around 20% from online, agency, and other channels [1] - Overall sales performance across all channels has shown little change compared to the same period last year [1]